Dr Sangeetha Paramasivan
BDS(India), MSc(Middx.), PGDip(UWL), PhD(UWL)
Current positions
Senior Research Fellow in Qualitative Methodology Research
Bristol Medical School (PHS)
Contact
Press and media
Many of our academics speak to the media as experts in their field of research. If you are a journalist, please contact the University’s Media and PR Team:
Research interests
Sangeetha is a Senior Research Fellow in Qualitative Research Methodology. She works within the QuinteT team that specialises in identifying and addressing recruitment issues in challenging randomised controlled trials (RCTs) and was previously employed by the MRC-funded ConDuCT-II methodology hub. Her research interests include optimising ethnic minority participation in clinical trials and trials methodology research in low- and middle-income countries.
Projects and supervisions
Research projects
IB 8071 MRC-NIHR TMRP via Liverpool: Optimising Informed CONsent in clinical trials in low- and middle-income settings: feasibility of an adapted QuinteT Recruitment Intervention (QRI) in India (OrION-I)
Principal Investigator
Managing organisational unit
Bristol Medical School (PHS)Dates
01/06/2020 to 31/08/2021
Addressing the public health crisis of child sexual abuse in India
Role
Collaborator
Description
International Strategic Fund Award (January 2020)
Overview:
Funding is requested for two trips: 1. Visiting NIMHANS is intended to initiate/develop collaborations for a future project that aims to develop interventions…Managing organisational unit
Bristol Medical School (PHS)Dates
01/01/2020 to 31/12/2020
Publications
Recent publications
01/03/2024Most UK cardiovascular disease trial protocols feature criteria that exclude ethnic minority participants
Journal of Clinical Epidemiology
Trials Methodology Research
The Lancet Regional Health - Southeast Asia
Non-COVID-19 UK clinical trials and the COVID-19 pandemic
Trials
What are patients told about innovative surgical procedures?
Annals of Surgery
Development of a new adapted Quintet Recruitment Intervention (QRI-Two) for rapid application to RCTs underway with enrolment shortfalls - to identify previously hidden barriers and improve recruitment
Trials